This brand name is authorized in Israel
The drug CALCILESS contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Potassium phosphate
UNII 4J9FJ0HL51 - MONOBASIC POTASSIUM PHOSPHATE
|
|
Potassium is the principle cation in intracellular fluid. It is involved with carbohydrate metabolism, glycogen storage and protein synthesis. It is involved with transmembrane potential and profound effects on muscle. Phosphorus has many important biochemical functions in the body and is involved in many significant metabolic and enzyme reactions in almost all organs and tissues. |
|
2
Sodium phosphate
UNII 22ADO53M6F - SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
|
|
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 2001 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
